Market Value1,735,092,000
Total Holdings67
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HZNP / Horizon Therapeutics Plc
CLDX / Celldex Therapeutics, Inc.
ALGN / Align Technology, Inc.
ATHA / LeonaBio, Inc.
OTIC / Otonomy Inc
ARK ETF TR / Genomic Rev ETF Put (00214Q952)
CYT / Cyteir Therapeutics, Inc.
OEF / iShares Trust - iShares S&P 100 ETF Put
AMGN / Amgen Inc.
QURE / uniQure N.V.
APTO / Aptose Biosciences Inc.
ALGS / Aligos Therapeutics, Inc.
CCXI / Churchill Capital Corp XI Call
PBYI / Puma Biotechnology, Inc.
INZY / Inozyme Pharma, Inc.
XLB / The Select Sector SPDR Trust - State Street Materials Select Sector SPDR ETF Put
INSM / Insmed Incorporated
MIRM / Mirum Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
EXEL / Exelixis, Inc.
REPL / Replimune Group, Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
PODD / Insulet Corporation
AVTE / Aerovate Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
OBSV / ObsEva SA.
KURA / Kura Oncology, Inc.
FGEN / FibroGen, Inc. Put
HRTX / Heron Therapeutics, Inc. Call
SNDX / Syndax Pharmaceuticals, Inc.
ARNA / Arena Pharmaceuticals Inc
PDSB / PDS Biotechnology Corporation
VRTX / Vertex Pharmaceuticals Incorporated
FATE / Fate Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
NCNA / NuCana plc - Depositary Receipt (Common Stock)
AKUS / Akouos Inc
TCRR / Tcr2 Therapeutics Inc Put
ASND / Ascendis Pharma A/S
14161H108 / Cardtronics PLC
CMPI / Checkmate Pharmaceuticals Inc
CCXI / Churchill Capital Corp XI Put
CALA / Calithera Biosciences, Inc.
SVRA / Savara Inc.
NBIX / Neurocrine Biosciences, Inc.
XLRN / Acceleron Pharma Inc
AGIO / Agios Pharmaceuticals, Inc.
CCXI / Churchill Capital Corp XI
RETA / Reata Pharmaceuticals Inc - Class A
ITCI / Intra-Cellular Therapies, Inc.
SRRA / Sierra Oncology Inc
JNCE / Jounce Therapeutics Inc
HRTX / Heron Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
JAZZ / Jazz Pharmaceuticals plc
PTGX / Protagonist Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
CYTK / Cytokinetics, Incorporated
RGNX / REGENXBIO Inc.
MRTX / Mirati Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
BIIB / Biogen Inc.
CTIC / CTI BioPharma Corp
NXTC / NextCure, Inc.
MRUS / Merus N.V.
PTCT / PTC Therapeutics, Inc.
LLY / Eli Lilly and Company
YMAB / Y-mAbs Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
GRTX / Galera Therapeutics, Inc.
SYBX / Synlogic, Inc.
IMTX / Immatics N.V.
SRPT / Sarepta Therapeutics, Inc.
AGEN / Agenus Inc.
GILD / Gilead Sciences, Inc. Call
UTHR / United Therapeutics Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
VERA / Vera Therapeutics, Inc.
NTRA / Natera, Inc.
MRNS / Marinus Pharmaceuticals, Inc.